Skip to search
Skip to main content
Back to Search
Start Over
Nivolumab plus doxorubicin, vinblastine, and dacarbazine (N-AVD) for newly diagnosed advanced-stage classical Hodgkin lymphoma (cHL): results from Cohort D of the phase 2 CheckMate 205 study
Authors :
Engert, A. Domingo Domenech, E. Rueda, A. Armand, P. Trneny, M. Feldman, T. Ansell, S. Provencio, M. Jaeger, U. Cohen, J. B. Savage, K. J. Willenbacher, W. Sacchi, M. Sumbul, A. Ramchandren, R. Engert, A. Domingo Domenech, E. Rueda, A. Armand, P. Trneny, M. Feldman, T. Ansell, S. Provencio, M. Jaeger, U. Cohen, J. B. Savage, K. J. Willenbacher, W. Sacchi, M. Sumbul, A. Ramchandren, R.
Publication Year :
2018
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1364915259
Document Type :
Electronic Resource